Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trialKi Hong Choi, Joo-Yong Hahn, Yong Hwan Park et al.|The Lancet|2025Cited by 86
Impact of Atrial Fibrillation on Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): The K-TAVI RegistrySang Yoon Lee, Seung‐Hyuk Choi, Junhong Kim et al.|Yonsei Medical Journal|2023Cited by 12
Three-Year Clinical Outcomes of a Thin-Strut Biodegradable-Polymer Everolimus-Eluting Stent in Patients With Acute Coronary SyndromeDoo Sun Sim, Jang‐Ho Bae, Dae Young Hyun et al.|Journal of Cardiovascular Intervention|2022Cited by 3
Clopidogrel vs Aspirin According to Diabetes MellitusSang Yoon Lee, Kyeong Ho Yun, Donghyeon Joo et al.|JACC: Cardiovascular Interventions|2026Cited by 0
Clopidogrel Versus Aspirin Monotherapy in High-Risk Patients after Percutaneous Coronary Intervention (SMART-CHOICE 3): A Randomised, Open-Label, Multicentre TrialKi Hong Choi, anon Investigators, Yong Hwan Park et al.|SSRN Electronic Journal|2025Cited by 0